Cite Filings / CCCC / 0001628280-26-002010

Feed Companies Filings Check

Sign in

8-K

Current Report

C4 Therapeutics, Inc. Filed 2026-01-14 Acc 0001628280-26-002010

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , cccc-20260114.htm

Around this filing

2026-02-26 8-K Results of operations
2026-01-16 4 Chief Medical Officer sold 10,000 shares at $2.22 ($22,200)
2026-01-14 8-K Regulation FD disclosure
2025-11-06 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading cccc-20260114.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…